S. Stine

发表

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

W. Ling, D. Raisch, J. Renner, 2003, The New England journal of medicine.

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.

H. Jones, A. Arria, S. Heil, 2012, Addiction.

Psychopharmacologic management of opioid-dependent women during pregnancy.

H. Jones, A. Arria, S. Heil, 2009, The American journal on addictions.

Smoking in Pregnant Women Screened for an Opioid Agonist Medication Study Compared to Related Pregnant and Non-Pregnant Patient Samples

H. Jones, K. O’grady, A. Arria, 2009, The American journal of drug and alcohol abuse.

Cigarette Smoking and Neonatal Outcomes in Depressed and Nondepressed Opioid-dependent Agonist-Maintained Pregnant Patients

Shauna P. Acquavita, H. Jones, S. Heil, 2011, Addictive disorders & their treatment.

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.

H. Jones, K. O’grady, A. Arria, 2012, Addiction.

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Amber M. Holbrook, Amy L. Salisbury, H. Jones, 2012, Addiction.

Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.

T. Kosten, A. Oliveto, S. Stine, 2005, Drug and alcohol dependence.

Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine.

Amber M. Holbrook, H. Jones, S. Heil, 2012, Addiction.

Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.

Amber M. Holbrook, H. Jones, K. O’grady, 2012, Addiction.

Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: a preliminary study.

M. Greenwald, K. Schuh, S. Stine, 2003, The American journal on addictions.

Effect of Methadone Dose on Cocaine Abuse in a Methadone Program

D. Charney, T. Kosten, S. Stine, 1992 .

Unintended pregnancy in opioid-abusing women.

H. Jones, A. Arria, S. Heil, 2011, Journal of substance abuse treatment.

Clinical Characteristics of Central European and North American Samples of Pregnant Women Screened for Opioid Agonist Treatment

H. Jones, A. Arria, S. Heil, 2010, European Addiction Research.

Neonatal abstinence syndrome after methadone or buprenorphine exposure.

H. Jones, K. O’grady, A. Arria, 2010, The New England journal of medicine.

Cocaine Precipitation of Patient-Identified Opiate Withdrawal

T. Kosten, S. Stine, S. Satel, 1993 .

Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.

H. Jones, A. Arria, S. Heil, 2010, The American journal on addictions.

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.

G. Badger, H. Jones, A. Arria, 2012, Addiction.

Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.

Amy L. Salisbury, H. Jones, K. O’grady, 2018, Drug and alcohol dependence.

Treatment of opioid-dependent pregnant women: clinical and research issues.

H. Jones, K. O’grady, A. Arria, 2008, Journal of substance abuse treatment.

Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.

Amber M. Holbrook, H. Jones, S. Heil, 2013, Drug and alcohol dependence.

Comments on: Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy

H. Jones, K. O’grady, A. Arria, 2012, Journal of addictive diseases.

Fetal assessment before and after dosing with buprenorphine or methadone.

Amy L. Salisbury, H. Jones, K. O’grady, 2012, Addiction.

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

W. Ling, S. Batki, J. Renner, 1998, Addiction.

Use of cocaine to prevent opiate withdrawal.

M. Sullivan, T. Kosten, M. Rosen, 1992, American Journal of Psychiatry.

Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine

C. Grillon, J. Krystal, D. Charney, 2001, Psychopharmacology.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Jeffrey J. Annon, Thomas E. Freese, W. Ling, 2004, The American journal on addictions.

Methadone dose for cocaine abuse.

T. Kosten, S. Stine, B. Burns, 1991, The American journal of psychiatry.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

W. Ling, L. Amass, J. Annon, 2009, Drug and alcohol dependence.

Use of drug combinations in treatment of opioid withdrawal.

T. Kosten, S. Stine, 1992, Journal of clinical psychopharmacology.

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

H. Jones, K. O’grady, A. Arria, 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.

R. Rosenheck, B. Rounsaville, T. Kosten, 1999, The American journal of psychiatry.

Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.

T. Kosten, S. Stine, 1994, The American journal of drug and alcohol abuse.

Mazindol treatment for cocaine dependence.

J. Krystal, D. Charney, T. Kosten, 1995, Drug and alcohol dependence.

Evolution and innovation in the agonist treatment of opioid-dependent pregnant women: development of a multi-center randomized controlled clinical trial

H. Jones, A. Arria, S. Heil, 2008 .

Effect of alpha-methyl-para-tyrosine on response to cocaine challenge

J. Krystal, P. Jatlow, G. Heninger, 1997, Biological Psychiatry.

Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients

S. Southwick, J. Krystal, D. Charney, 2002, Biological Psychiatry.

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.

A. Feingold, T. Kosten, A. Oliveto, 2003, Drug and alcohol dependence.

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned.

H. Jones, K. O’grady, A. Arria, 2012, Addiction.

New treatments for opiate dependence

T. Kosten, S. Stine, 1997 .

Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy?

T. Winhusen, S. Ondersma, S. Stine, 2009, Drug and alcohol dependence.

Characteristics of Opioid-Using Pregnant Women Who Accept or Refuse Participation in a Clinical Trial: Screening Results from the MOTHER Study

H. Jones, A. Arria, S. Heil, 2009, The American journal of drug and alcohol abuse.

Evidence for Ascending and Descending Intraspinal as Well as Primary Sensory Somatostatin Projections in the Rat Spinal Cord

E. Costa, S. Stine, Hsiu‐Ying T. Yang, 1982, Journal of neurochemistry.

AMPT Effects on Cue-Induced Craving for Cocaine

J. Krystal, D. Charney, T. Kosten, 1996 .

Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.

Amy L. Salisbury, H. Jones, K. O’grady, 2018, Drug and alcohol dependence.